Tag: Seniors
2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS
More than three-quarters of prescriptions were for a supply of more than seven days; 55 percent for 15 to 30 days
Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination
Increased risk for myocarditis, pericarditis seen one to two weeks after COVID-19 mRNA vaccination
Poll Finds Public Fears Over RSV Have Eased, Although It Remains a Threat
Wayfinding Task on Smartphone Can Detect Subjective Cognitive Decline
Performance measures extracted from GPS and user data differentiated between those with subjective cognitive decline, cognitively healthy adults
Fatal Falls After Age 45 Years Cost More Than Fatal Firearm Injuries
Combined cost, including medical costs and value of statistical life, higher for fatal falls among those aged 45 to 85-plus years
Incident Stroke Tied to Acute, Accelerated Long-Term Cognitive Decline
Substantial acute decline seen in global cognition and all cognitive domains; accelerated decline also seen in global cognition
Guidelines Provided for Diagnosis of Pediatric, Late-Onset Multiple Sclerosis
Unique biological features seen in children younger than 18 years, adults older than 50 years compared with typical adult-onset MS
Incidence of Cardiovascular Disease Higher for Seniors With Cancer
Greatest incidence seen for metastatic, hematological, and lung cancer; increased risk for CVD seen with chemotherapy
Cognitively Stimulating Leisure Activity Protects From Further Cognitive Decline
Optimal level of programming is at least three to four times a week in older adults with mild cognitive impairment
Statin Therapy Cost-Effectively Improves Health Outcomes for ≥70s
Lifetime use of standard statin increased QALYs by 0.24 to 0.70, with further increase seen for higher-intensity statins
